These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 31857571)

  • 61. Quantitative measurement of XLR11 and UR-144 in oral fluid by LC-MS-MS.
    Amaratunga P; Thomas C; Lemberg BL; Lemberg D
    J Anal Toxicol; 2014; 38(6):315-21. PubMed ID: 24812645
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Chemical analysis of synthetic cannabinoids as designer drugs in herbal products.
    Uchiyama N; Kikura-Hanajiri R; Ogata J; Goda Y
    Forensic Sci Int; 2010 May; 198(1-3):31-8. PubMed ID: 20117892
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A case of cannabinoid hyperemesis syndrome caused by synthetic cannabinoids.
    Hopkins CY; Gilchrist BL
    J Emerg Med; 2013 Oct; 45(4):544-6. PubMed ID: 23890687
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Supraventricular tachycardia and acute confusion following ingestion of e-cigarette fluid containing AB-FUBINACA and ADB-FUBINACA: a case report with quantitative analysis of serum drug concentrations.
    Lam RPK; Tang MHY; Leung SC; Chong YK; Tsui MSH; Mak TWL
    Clin Toxicol (Phila); 2017 Aug; 55(7):662-667. PubMed ID: 28393558
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Determination of XLR-11 and its metabolites in hair by liquid chromatography-tandem mass spectrometry.
    Park M; Yeon S; Lee J; In S
    J Pharm Biomed Anal; 2015 Oct; 114():184-9. PubMed ID: 26070160
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Phase I metabolism of the carbazole-derived synthetic cannabinoids EG-018, EG-2201, and MDMB-CHMCZCA and detection in human urine samples.
    Mogler L; Franz F; Wilde M; Huppertz LM; Halter S; Angerer V; Moosmann B; Auwärter V
    Drug Test Anal; 2018 Sep; 10(9):1417-1429. PubMed ID: 29726116
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Hemorrhagic Soft Tissue Upper Airway Obstruction From Brodifacoum-Contaminated Synthetic Cannabinoid.
    Ross CH; Singh P; Simon EL
    J Emerg Med; 2019 Jul; 57(1):47-50. PubMed ID: 31078349
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Three fatalities associated with the synthetic cannabinoids 5F-ADB, 5F-PB-22, and AB-CHMINACA.
    Angerer V; Jacobi S; Franz F; Auwärter V; Pietsch J
    Forensic Sci Int; 2017 Dec; 281():e9-e15. PubMed ID: 29133010
    [TBL] [Abstract][Full Text] [Related]  

  • 69. In vivo detection of the new psychoactive substance AM-694 and its metabolites.
    Bertol E; Vaiano F; Di Milia MG; Mari F
    Forensic Sci Int; 2015 Nov; 256():21-7. PubMed ID: 26295909
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Synthesis and pharmacology of new psychoactive substance 5F-CUMYL-P7AICA, a scaffold- hopping analog of synthetic cannabinoid receptor agonists 5F-CUMYL-PICA and 5F-CUMYL-PINACA.
    Banister SD; Adams A; Kevin RC; Macdonald C; Glass M; Boyd R; Connor M; McGregor IS; Havel CM; Bright SJ; Vilamala MV; Lladanosa CG; Barratt MJ; Gerona RR
    Drug Test Anal; 2019 Feb; 11(2):279-291. PubMed ID: 30151911
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The Pharmacologic and Clinical Effects of Illicit Synthetic Cannabinoids.
    White CM
    J Clin Pharmacol; 2017 Mar; 57(3):297-304. PubMed ID: 27610597
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The detection of the urinary metabolites of 1-[(5-fluoropentyl)-1H-indol-3-yl]-(2-iodophenyl)methanone (AM-694), a high affinity cannabimimetic, by gas chromatography - mass spectrometry.
    Grigoryev A; Kavanagh P; Melnik A
    Drug Test Anal; 2013 Feb; 5(2):110-5. PubMed ID: 22522907
    [TBL] [Abstract][Full Text] [Related]  

  • 73. New-Onset Refractory Status Epilepticus Associated With the Use of Synthetic Cannabinoids.
    Patel NA; Jerry JM; Jimenez XF; Hantus ST
    Psychosomatics; 2017; 58(2):180-186. PubMed ID: 28366218
    [No Abstract]   [Full Text] [Related]  

  • 74. Atrial fibrillation following synthetic cannabinoid abuse.
    Efe TH; Felekoglu MA; Çimen T; Doğan M
    Turk Kardiyol Dern Ars; 2017 Jun; 45(4):362-364. PubMed ID: 28595208
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Combination Chemistry: Structure-Activity Relationships of Novel Psychoactive Cannabinoids.
    Wiley JL; Marusich JA; Thomas BF
    Curr Top Behav Neurosci; 2017; 32():231-248. PubMed ID: 27753007
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Partial status epilepticus causing a transient left ventricular apical ballooning.
    Benyounes N; Obadia M; Devys JM; Thevenin A; Iglesias S
    Seizure; 2011 Mar; 20(2):184-6. PubMed ID: 21134768
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cardiotoxicity associated with the synthetic cannabinoid, K9, with laboratory confirmation.
    Young AC; Schwarz E; Medina G; Obafemi A; Feng SY; Kane C; Kleinschmidt K
    Am J Emerg Med; 2012 Sep; 30(7):1320.e5-7. PubMed ID: 21802885
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The use of vasopressors in Takotsubo cardiomyopathy: impact on neurological practice.
    Rathakrishnan R; Lee YP
    Int J Cardiol; 2010 Nov; 145(1):131; author reply 132. PubMed ID: 19619905
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Delayed seizure-like activity following analytically confirmed use of previously unreported synthetic cannabinoid analogues.
    Schep LJ; Slaughter RJ; Hudson S; Place R; Watts M
    Hum Exp Toxicol; 2015 May; 34(5):557-60. PubMed ID: 25233895
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Critical Illness Secondary to Synthetic Cannabinoid Ingestion.
    Kourouni I; Mourad B; Khouli H; Shapiro JM; Mathew JP
    JAMA Netw Open; 2020 Jul; 3(7):e208516. PubMed ID: 32687586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.